{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:36:25Z","timestamp":1778625385202,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T00:00:00Z","timestamp":1499731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T00:00:00Z","timestamp":1499731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA196701"],"award-info":[{"award-number":["CA196701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA138264"],"award-info":[{"award-number":["R01 CA138264"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["PF-13-174-01-CSM"],"award-info":[{"award-number":["PF-13-174-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12918-017-0445-x","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T01:15:29Z","timestamp":1499735729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1002-9467","authenticated-orcid":false,"given":"Kerri-Ann","family":"Norton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan B.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander S.","family":"Popel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"445_CR1","volume-title":"Breast Cancer Facts & Figures 2015\u20132016","author":"American Cancer Society","year":"2015","unstructured":"American Cancer Society. Breast Cancer Facts & Figures 2015\u20132016. Atlanta:American: Cancer Society, Inc; 2015."},{"issue":"1","key":"445_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10585-013-9610-9","volume":"31","author":"E Lee","year":"2014","unstructured":"Lee E, Pandey NB, Popel AS. Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model. Clin Exp metastasis. 2014;31(1):67\u201379. PubMed PMID: 23963763. Pubmed Central PMCID: 3947147","journal-title":"Clin Exp metastasis"},{"key":"445_CR3","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1038\/ncomms5715","volume":"5","author":"E Lee","year":"2014","unstructured":"Lee E, Fertig EJ, Jin K, Sukumar S, Pandey NB, Popel AS. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun. 2014;5:4715. PubMed PMID: 25178650. Pubmed Central PMCID: 4351998","journal-title":"Nat Commun"},{"key":"445_CR4","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1038\/srep05853","volume":"4","author":"E Lee","year":"2014","unstructured":"Lee E, Pandey NB, Popel AS. Lymphatic endothelial cells support tumor growth in breast cancer. Sci Rep. 2014;4:5853. PubMed PMID: 25068296","journal-title":"Sci Rep"},{"key":"445_CR5","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2015.2","volume":"17","author":"E Lee","year":"2015","unstructured":"Lee E, Pandey NB, Popel AS. Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment. Expert Rev Mol Med. 2015;17:e3. PubMed PMID: 25634527. Pubmed Central PMCID: 4352000","journal-title":"Expert Rev Mol Med"},{"issue":"7162","key":"445_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557\u201363. PubMed PMID: 17914389","journal-title":"Nature"},{"issue":"15","key":"445_CR7","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1158\/0008-5472.CAN-11-3917","volume":"72","author":"M Velasco-Velazquez","year":"2012","unstructured":"Velasco-Velazquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, et al. CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res. 2012;72(15):3839\u201350. PubMed PMID: 22637726","journal-title":"Cancer Res"},{"issue":"23","key":"445_CR8","doi-asserted-by":"publisher","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-14-0612","volume":"74","author":"D Sicoli","year":"2014","unstructured":"Sicoli D, Jiao X, Ju X, Velasco-Velazquez M, Ertel A, Addya S, et al. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines. Cancer Res. 2014;74(23):7103\u201314. PubMed PMID: 25452256. Pubmed Central PMCID: 4294544","journal-title":"Cancer Res"},{"issue":"2","key":"445_CR9","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","volume":"13","author":"L Vermeulen","year":"2012","unstructured":"Vermeulen L. De Sousa e Melo F, Richel DJ, Medema JP. The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol. 2012;13(2):e83\u20139. PubMed PMID: 22300863","journal-title":"Lancet Oncol"},{"issue":"4","key":"445_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.biocel.2011.12.020","volume":"44","author":"MA Velasco-Velazquez","year":"2012","unstructured":"Velasco-Velazquez MA, Homsi N, De La Fuente M, Pestell RG. Breast cancer stem cells. Int J Biochem Cell Biol. 2012;44(4):573\u20137. PubMed PMID: 22249027. Pubmed Central PMCID: 3294043","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"445_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3748\/wjg.v20.i4.923","volume":"20","author":"C Fanali","year":"2014","unstructured":"Fanali C, Lucchetti D, Farina M, Corbi M, Cufino V, Cittadini A, et al. Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. World J Gastroenterol. 2014;20(4):923\u201342. PubMed PMID: 24574766. Pubmed Central PMCID: 3921545","journal-title":"World J Gastroenterol"},{"key":"445_CR12","doi-asserted-by":"crossref","unstructured":"Garner EF, Beierle EA. Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma. Cancers (Basel). 2015;8(1):5. PubMed PMID: 26729169. Pubmed Central PMCID: 4728452.","DOI":"10.3390\/cancers8010005"},{"issue":"1","key":"445_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2012.08.014","volume":"338","author":"A Lundin","year":"2013","unstructured":"Lundin A, Driscoll B. Lung cancer stem cells: progress and prospects. Cancer Lett. 2013;338(1):89\u201393. PubMed PMID: 22906416. Pubmed Central PMCID: 3686996","journal-title":"Cancer Lett"},{"issue":"1","key":"445_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","volume":"2","author":"S Liu","year":"2014","unstructured":"Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2014;2(1):78\u201391. PubMed PMID: 24511467. Pubmed Central PMCID: 3916760","journal-title":"Stem Cell Rep"},{"issue":"1","key":"445_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clbc.2012.09.017","volume":"13","author":"S Gangopadhyay","year":"2013","unstructured":"Gangopadhyay S, Nandy A, Hor P, Mukhopadhyay A. Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer. 2013;13(1):7\u201315. PubMed PMID: 23127340","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"445_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jclinpath-2012-201169","volume":"66","author":"FF de Beca","year":"2013","unstructured":"de Beca FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, et al. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol. 2013;66(3):187\u201391. PubMed PMID: 23112116","journal-title":"J Clin Pathol"},{"issue":"10","key":"445_CR17","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/emmm.201302558","volume":"5","author":"DJ Azzam","year":"2013","unstructured":"Azzam DJ, Zhao D, Sun J, Minn AJ, Ranganathan P, Drews-Elger K, et al. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in gamma-secretase inhibitor drug responses. EMBO Mol Med. 2013;5(10):1502\u201322. PubMed PMID: 23982961. Pubmed Central PMCID: 3799576","journal-title":"EMBO Mol Med"},{"issue":"4","key":"445_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3892\/or_00000312","volume":"21","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Yao F, Yao X, Yi C, Tan C, Wei L, et al. Role of CCL5 in invasion, proliferation and proportion of CD44+\/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep. 2009;21(4):1113\u201321. PubMed PMID: 19288016","journal-title":"Oncol Rep"},{"key":"445_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2014.04.001","volume":"30","author":"Z Wang","year":"2015","unstructured":"Wang Z, Butner JD, Kerketta R, Cristini V, Deisboeck TS. Simulating cancer growth with multiscale agent-based modeling. Semin Cancer Biol. 2015;30:70\u20138. PubMed PMID: 24793698. Pubmed Central PMCID: 4216775","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"445_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drudis.2014.09.026","volume":"20","author":"SD Finley","year":"2015","unstructured":"Finley SD, Chu L-H, Popel AS. Computational systems biology approaches to anti-angiogenic cancer therapeutics. Drug Discov Today. 2015;20(2):187\u201397.","journal-title":"Drug Discov Today"},{"issue":"5","key":"445_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2015.11.002","volume":"163","author":"F Michor","year":"2015","unstructured":"Michor F, Beal K. Improving cancer treatment via mathematical modeling: surmounting the challenges is worth the effort. Cell. 2015;163(5):1059\u201363. PubMed PMID: 26590416. Pubmed Central PMCID: 4676401","journal-title":"Cell"},{"issue":"12","key":"445_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrc4029","volume":"15","author":"PM Altrock","year":"2015","unstructured":"Altrock PM, Liu LL, Michor F. The mathematics of cancer: integrating quantitative models. Nat Rev Cancer. 2015;15(12):730\u201345. PubMed PMID: 26597528","journal-title":"Nat Rev Cancer"},{"key":"445_CR23","doi-asserted-by":"crossref","unstructured":"Enderling H, Rejniak KA. Simulating cancer: computational models in oncology. Frontiers in oncology. 2013;3.","DOI":"10.3389\/fonc.2013.00233"},{"issue":"11","key":"445_CR24","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1007\/s10439-012-0655-8","volume":"40","author":"A Chakrabarti","year":"2012","unstructured":"Chakrabarti A, Verbridge S, Stroock AD, Fischbach C, Varner JD. Multiscale models of breast cancer progression. Ann Biomed Eng. 2012;40(11):2488\u2013500. PubMed PMID: 23008097. Pubmed Central PMCID: 3868441","journal-title":"Ann Biomed Eng"},{"issue":"4","key":"445_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jtbi.2004.08.032","volume":"232","author":"SJ Franks","year":"2005","unstructured":"Franks SJ, Byrne HM, Underwood JC, Lewis CE. Biological inferences from a mathematical model of comedo ductal carcinoma in situ of the breast. J Theor Biol. 2005;232(4):523\u201343. PubMed PMID: 15588633","journal-title":"J Theor Biol"},{"issue":"1","key":"445_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jtbi.2007.02.019","volume":"247","author":"KA Rejniak","year":"2007","unstructured":"Rejniak KA. An immersed boundary framework for modelling the growth of individual cells: an application to the early tumour development. J Theor Biol. 2007;247(1):186\u2013204. PubMed PMID: 17416390","journal-title":"J Theor Biol"},{"issue":"5","key":"445_CR27","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1007\/s11538-008-9308-3","volume":"70","author":"KA Rejniak","year":"2008","unstructured":"Rejniak KA, Anderson AR. A computational study of the development of epithelial acini: II. Necessary conditions for structure and lumen stability. Bull Math Biol. 2008;70(5):1450\u201379. PubMed PMID: 18401665. Pubmed Central PMCID: 3812684","journal-title":"Bull Math Biol"},{"issue":"3","key":"445_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11538-007-9274-1","volume":"70","author":"KA Rejniak","year":"2008","unstructured":"Rejniak KA, Anderson AR. A computational study of the development of epithelial acini: I. Sufficient conditions for the formation of a hollow structure. Bull Math Biol. 2008;70(3):677\u2013712. PubMed PMID: 18188652. Pubmed Central PMCID: 3812693","journal-title":"Bull Math Biol"},{"key":"445_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jtbi.2012.02.002","volume":"301","author":"P Macklin","year":"2012","unstructured":"Macklin P, Edgerton ME, Thompson AM, Cristini V. Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol. 2012;301:122\u201340. PubMed PMID: 22342935. Pubmed Central PMCID: 3322268","journal-title":"J Theor Biol"},{"issue":"10","key":"445_CR30","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1158\/0008-5472.CAN-08-3740","volume":"69","author":"HB Frieboes","year":"2009","unstructured":"Frieboes HB, Edgerton ME, Fruehauf JP, Rose FR, Worrall LK, Gatenby RA, et al. Prediction of drug response in breast cancer using integrative experimental\/computational modeling. Cancer Res. 2009;69(10):4484\u201392. PubMed PMID: 19366802. Pubmed Central PMCID: 2720602","journal-title":"Cancer Res"},{"issue":"12","key":"445_CR31","doi-asserted-by":"publisher","first-page":"e1003997","DOI":"10.1371\/journal.pcbi.1003997","volume":"10","author":"E Boghaert","year":"2014","unstructured":"Boghaert E, Radisky DC, Nelson CM. Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state. PLoS Comput Biol. 2014;10(12):e1003997. PubMed PMID: 25473842. Pubmed Central PMCID: 4256017","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"445_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.18632\/oncotarget.979","volume":"4","author":"DC Radisky","year":"2013","unstructured":"Radisky DC, Nelson CM. Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion. Oncotarget. 2013;4(4):498\u20139. PubMed PMID: 23625757. Pubmed Central PMCID: 3720598","journal-title":"Oncotarget"},{"key":"445_CR33","first-page":"278","volume":"3","author":"M Kim","year":"2013","unstructured":"Kim M, Gillies RJ, Rejniak KA. Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues. Front Oncol. 2013;3:278. PubMed PMID: 24303366. Pubmed Central PMCID: 3831268","journal-title":"Front Oncol"},{"key":"445_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/8415_2012_150","volume-title":"Multiscale computer modeling in biomechanics and biomedical engineering","author":"P Macklin","year":"2013","unstructured":"Macklin P, Mumenthaler S, Lowengrub J. Modeling multiscale necrotic and calcified tissue biomechanics in cancer patients: application to Ductal carcinoma in situ (DCIS). In: Gefen A, editor. Multiscale computer modeling in biomechanics and biomedical engineering. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. p. 349\u201380."},{"issue":"4","key":"445_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jtbi.2009.11.024","volume":"263","author":"KA Norton","year":"2010","unstructured":"Norton KA, Wininger M, Bhanot G, Ganesan S, Barnard N, Shinbrot T. A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression. J Theor Biol. 2010;263(4):393\u2013406. PubMed PMID: 20006623. Pubmed Central PMCID: 2839055","journal-title":"J Theor Biol"},{"issue":"100","key":"445_CR36","doi-asserted-by":"publisher","first-page":"20140640","DOI":"10.1098\/rsif.2014.0640","volume":"11","author":"KA Norton","year":"2014","unstructured":"Norton KA, Popel AS. An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location. J R Soc Interface. 2014;11(100):20140640. PubMed PMID: 25185580. Pubmed Central PMCID: 4191089","journal-title":"J R Soc Interface"},{"key":"445_CR37","doi-asserted-by":"publisher","first-page":"36992","DOI":"10.1038\/srep36992","volume":"6","author":"KA Norton","year":"2016","unstructured":"Norton KA, Popel AS. Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis. Sci Rep. 2016;6:36992. PubMed PMID: 27841344. Pubmed Central PMCID: 5107954","journal-title":"Sci Rep"},{"key":"445_CR38","doi-asserted-by":"crossref","unstructured":"Poleszczuk J, Macklin P, Enderling H. Agent-based modeling of cancer stem cell driven solid tumor growth. Totowa, NJ: Humana Press. 2016;1-12.","DOI":"10.1155\/2016\/3923527"},{"issue":"4","key":"445_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10441-010-9111-z","volume":"58","author":"H Enderling","year":"2010","unstructured":"Enderling H, Chaplain MA, Hahnfeldt P. Quantitative modeling of tumor dynamics and radiotherapy. Acta Biotheor. 2010;58(4):341\u201353. PubMed PMID: 20658170","journal-title":"Acta Biotheor"},{"key":"445_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1745-6150-5-23","volume":"5","author":"H Enderling","year":"2010","unstructured":"Enderling H, Hlatky L, Hahnfeldt P. Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype. Biol Direct. 2010;5:23. PubMed PMID: 20406441. Pubmed Central PMCID: 2868833","journal-title":"Biol Direct"},{"key":"445_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-4682-9-31","volume":"9","author":"H Enderling","year":"2012","unstructured":"Enderling H, Hlatky L, Hahnfeldt P. Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth. Theor Biol Med Model. 2012;9:31. PubMed PMID: 22838395. Pubmed Central PMCID: 3499182","journal-title":"Theor Biol Med Model"},{"issue":"9","key":"445_CR42","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1158\/0008-5472.CAN-11-3269","volume":"72","author":"H Enderling","year":"2012","unstructured":"Enderling H, Hahnfeldt P, Hlatky L, Almog N. Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy. Cancer Res. 2012;72(9):2172\u20135. PubMed PMID: 22414579. Pubmed Central PMCID: 3374524","journal-title":"Cancer Res"},{"issue":"3","key":"445_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cpr.12101","volume":"47","author":"J Poleszczuk","year":"2014","unstructured":"Poleszczuk J, Hahnfeldt P, Enderling H. Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence. Cell Prolif. 2014;47(3):267\u201376. PubMed PMID: 24666838","journal-title":"Cell Prolif"},{"issue":"2","key":"445_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.pbiomolbio.2011.03.007","volume":"106","author":"H Enderling","year":"2011","unstructured":"Enderling H, Hahnfeldt P. Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer? Prog Biophys Mol Biol. 2011;106(2):391\u20139. PubMed PMID: 21473880","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"445_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/0008-5472.CAN-09-3663","volume":"70","author":"A Sottoriva","year":"2010","unstructured":"Sottoriva A, Verhoeff JJ, Borovski T, McWeeney SK, Naumov L, Medema JP, et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 2010;70(1):46\u201356. PubMed PMID: 20048071","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"445_CR46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","volume":"148","author":"H Haeno","year":"2012","unstructured":"Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012;148(1\u20132):362\u201375. PubMed PMID: 22265421. Pubmed Central PMCID: 3289413","journal-title":"Cell"},{"issue":"3","key":"445_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2013.12.029","volume":"156","author":"K Leder","year":"2014","unstructured":"Leder K, Pitter K, Laplant Q, Hambardzumyan D, Ross BD, Chan TA, et al. Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell. 2014;156(3):603\u201316. PubMed PMID: 24485463. Pubmed Central PMCID: 3923371","journal-title":"Cell"},{"issue":"9","key":"445_CR48","doi-asserted-by":"publisher","first-page":"e1004350","DOI":"10.1371\/journal.pcbi.1004350","volume":"11","author":"J Foo","year":"2015","unstructured":"Foo J, Liu LL, Leder K, Riester M, Iwasa Y, Lengauer C, et al. An evolutionary approach for identifying driver mutations in colorectal cancer. PLoS Comput Biol. 2015;11(9):e1004350. PubMed PMID: 26379039. Pubmed Central PMCID: 4575033","journal-title":"PLoS Comput Biol"},{"key":"445_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jtbi.2014.08.035","volume":"364","author":"I Kareva","year":"2015","unstructured":"Kareva I. Immune evasion through competitive inhibition: the shielding effect of cancer non-stem cells. J Theor Biol. 2015;364:40\u20138. PubMed PMID: 25195001","journal-title":"J Theor Biol"},{"key":"445_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-319-22909-6_7","volume":"882","author":"F Beca","year":"2016","unstructured":"Beca F, Polyak K. Intratumor heterogeneity in breast cancer. Adv Exp Med Biol. 2016;882:169\u201389. PubMed PMID: 26987535","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"445_CR51","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K. Heterogeneity in breast cancer. J Clin Invest. 2011;121(10):3786\u20138. PubMed PMID: 21965334. Pubmed Central PMCID: 3195489","journal-title":"J Clin Invest"},{"issue":"10","key":"445_CR52","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrc2212","volume":"7","author":"J Stingl","year":"2007","unstructured":"Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 2007;7(10):791\u20139. PubMed PMID: 17851544","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"445_CR53","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1118\/1.597707","volume":"23","author":"S Pohlman","year":"1996","unstructured":"Pohlman S, Powell KA, Obuchowski NA, Chilcote WA, Grundfest-Broniatowski S. Quantitative classification of breast tumors in digitized mammograms. Med Phys. 1996;23(8):1337\u201345. PubMed PMID: 8873030","journal-title":"Med Phys"},{"key":"445_CR54","unstructured":"El-Faramawy N, Rangayyan R, Desautels J, Alim O, editors. Shape factors for analysis of breast tumors in mammograms. Electrical and Computer Engineering, 1996 Canadian Conference on; 1996: Calgary; IEEE."},{"issue":"14","key":"445_CR55","first-page":"3683","volume":"60","author":"JW Baish","year":"2000","unstructured":"Baish JW, Jain RK. Fractals and cancer. Cancer Res. 2000;60(14):3683\u20138. PubMed PMID: 10919633","journal-title":"Cancer Res"},{"issue":"10","key":"445_CR56","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/1535-7163.MCT-13-0108","volume":"12","author":"H Song","year":"2013","unstructured":"Song H, Hedayati M, Hobbs RF, Shao C, Bruchertseifer F, Morgenstern A, et al. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody. Mol Cancer Ther. 2013;12(10):2043\u201354. PubMed PMID: 23873849. Pubmed Central PMCID: 3804319","journal-title":"Mol Cancer Ther"},{"key":"445_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biomaterials.2015.11.039","volume":"81","author":"N Peela","year":"2016","unstructured":"Peela N, Sam FS, Christenson W, Truong D, Watson AW, Mouneimne G, et al. A three dimensional micropatterned tumor model for breast cancer cell migration studies. Biomaterials. 2016;81:72\u201383. PubMed PMID: 26724455","journal-title":"Biomaterials"},{"issue":"5","key":"445_CR58","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1073\/pnas.1010396108","volume":"108","author":"R Poincloux","year":"2011","unstructured":"Poincloux R, Collin O, Lizarraga F, Romao M, Debray M, Piel M, et al. Contractility of the cell rear drives invasion of breast tumor cells in 3D Matrigel. Proc Natl Acad Sci U S A. 2011;108(5):1943\u20138. PubMed PMID: 21245302. Pubmed Central PMCID: 3033302","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"445_CR59","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cell.2014.02.052","volume":"157","author":"KM Stroka","year":"2014","unstructured":"Stroka KM, Jiang H, Chen S-H, Tong Z, Wirtz D, Sun SX, et al. Water permeation drives tumor cell migration in confined microenvironments. Cell. 2014;157(3):611\u201323.","journal-title":"Cell"},{"issue":"1","key":"445_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yexcr.2004.06.030","volume":"300","author":"S-J Wang","year":"2004","unstructured":"Wang S-J, Saadi W, Lin F, Nguyen CM-C, Jeon NL. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res. 2004;300(1):180\u20139.","journal-title":"Exp Cell Res"},{"issue":"2","key":"445_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ccr.2008.12.019","volume":"15","author":"S Yang","year":"2009","unstructured":"Yang S, Zhang JJ, Huang X-Y. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell. 2009;15(2):124\u201334.","journal-title":"Cancer Cell"},{"issue":"5","key":"445_CR62","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1349-7006.2012.02259.x","volume":"103","author":"S Lin","year":"2012","unstructured":"Lin S, Wan S, Sun L, Hu J, Fang D, Zhao R, et al. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia. Cancer Sci. 2012;103(5):904\u201312. PubMed PMID: 22380870","journal-title":"Cancer Sci"},{"issue":"3","key":"445_CR63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2217\/fvl.11.2","volume":"6","author":"BL Norton","year":"2011","unstructured":"Norton BL, Hicks CB. Maraviroc: the first chemokine coreceptor 5 inhibitor. Futur Virol. 2011;6(3):283\u201394.","journal-title":"Futur Virol"},{"issue":"3","key":"445_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10863-007-9085-y","volume":"39","author":"RJ Gillies","year":"2007","unstructured":"Gillies RJ, Gatenby RA. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr. 2007;39(3):251\u20137. PubMed PMID: 17624581","journal-title":"J Bioenerg Biomembr"},{"issue":"5\u20136","key":"445_CR65","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00138-002-0087-9","volume":"13","author":"KM Iftekharuddin","year":"2003","unstructured":"Iftekharuddin KM, Jia W, Marsh R. Fractal analysis of tumor in brain MR images. Mach Vis Appl. 2003;13(5\u20136):352\u201362.","journal-title":"Mach Vis Appl"},{"issue":"1","key":"445_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.physa.2003.09.013","volume":"331","author":"Y Mansury","year":"2004","unstructured":"Mansury Y, Deisboeck TS. Simulating \u2018structure\u2013function\u2019patterns of malignant brain tumors. Phys Stat Mech Appl. 2004;331(1):219\u201332.","journal-title":"Phys Stat Mech Appl"},{"issue":"2","key":"445_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10549-010-0914-z","volume":"126","author":"N Nyirenda","year":"2011","unstructured":"Nyirenda N, Farkas DL, Ramanujan VK. Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment. Breast Cancer Res Treat. 2011;126(2):345\u201354. PubMed PMID: 20446030. Pubmed Central PMCID: 2982889","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"445_CR68","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1172\/JCI57099","volume":"121","author":"H Korkaya","year":"2011","unstructured":"Korkaya H, Liu S, Wicha MS. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest. 2011;121(10):3804\u20139. PubMed PMID: 21965337. Pubmed Central PMCID: 3223613","journal-title":"J Clin Invest"},{"issue":"4","key":"445_CR69","first-page":"1295","volume":"5","author":"KA Norton","year":"2015","unstructured":"Norton KA, Popel AS, Pandey NB. Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer. Am J Cancer Res. 2015;5(4):1295\u2013307. PubMed PMID: 26101698. Pubmed Central PMCID: 4473311","journal-title":"Am J Cancer Res"},{"issue":"7568","key":"445_CR70","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature14971","volume":"525","author":"B Waclaw","year":"2015","unstructured":"Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, Nowak MA. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature. 2015;525(7568):261\u20134. PubMed PMID: 26308893. Pubmed Central PMCID: 4782800","journal-title":"Nature"},{"issue":"24","key":"445_CR71","doi-asserted-by":"crossref","first-page":"35703","DOI":"10.18632\/oncotarget.9601","volume":"7","author":"P Pellegrini","year":"2016","unstructured":"Pellegrini P, Dyczynski M, Sbrana FV, Karlgren M, Buoncervello M, Hagg-Olofsson M, et al. Tumor acidosis enhances cytotoxic effects and autophagy inhibition by salinomycin on cancer cell lines and cancer stem cells. Oncotarget. 2016;7(24):35703\u201323. PubMed PMID: 27248168","journal-title":"Oncotarget"},{"issue":"36","key":"445_CR72","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1038\/onc.2013.411","volume":"33","author":"SJ Vidal","year":"2014","unstructured":"Vidal SJ, Rodriguez-Bravo V, Galsky M, Cordon-Cardo C, Domingo-Domenech J. Targeting cancer stem cells to suppress acquired chemotherapy resistance. Oncogene. 2014;33(36):4451\u201363. PubMed PMID: 24096485","journal-title":"Oncogene"},{"issue":"7","key":"445_CR73","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.18632\/oncotarget.3278","volume":"6","author":"R Lamb","year":"2015","unstructured":"Lamb R, Harrison H, Smith DL, Townsend PA, Jackson T, Ozsvari B, et al. Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction. Oncotarget. 2015;6(7):4585\u2013601. PubMed PMID: 25671304. Pubmed Central PMCID: 4467101","journal-title":"Oncotarget"},{"issue":"2","key":"445_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26(2):225\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"445_CR75","doi-asserted-by":"crossref","unstructured":"Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, et al. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget. 2016;7816.","DOI":"10.18632\/oncotarget.6868"},{"issue":"5","key":"445_CR76","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1158\/1078-0432.CCR-0951-3","volume":"10","author":"GE Konecny","year":"2004","unstructured":"Konecny GE, Meng YG, Untch M, Wang HJ, Bauerfeind I, Epstein M, et al. Association between HER-2\/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. Clin Cancer Res. 2004;10(5):1706\u201316. PubMed PMID: 15014023","journal-title":"Clin Cancer Res"},{"issue":"6","key":"445_CR77","first-page":"1831","volume":"8","author":"M Schindl","year":"2002","unstructured":"Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 2002;8(6):1831\u20137. PubMed PMID: 12060624","journal-title":"Clin Cancer Res"},{"issue":"4","key":"445_CR78","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008;15(4):678\u201385. PubMed PMID: 18259193. Pubmed Central PMCID: 3050610","journal-title":"Cell Death Differ"},{"issue":"2","key":"445_CR79","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.bjc.6605486","volume":"102","author":"J Chen","year":"2010","unstructured":"Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer. 2010;102(2):351\u201360. PubMed PMID: WOS:000273728500015. English","journal-title":"Br J Cancer"},{"issue":"35","key":"445_CR80","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1038\/onc.2012.578","volume":"32","author":"GL Semenza","year":"2013","unstructured":"Semenza GL. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene. 2013;32(35):4057\u201363. PubMed PMID: 23222717. Pubmed Central PMCID: 4415159","journal-title":"Oncogene"},{"issue":"7","key":"445_CR81","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00109-011-0855-y","volume":"90","author":"CC Wong","year":"2012","unstructured":"Wong CC, Zhang H, Gilkes DM, Chen J, Wei H, Chaturvedi P, et al. Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J Mol Med (Berl). 2012;90(7):803\u201315. PubMed PMID: 22231744. Pubmed Central PMCID: 3437551","journal-title":"J Mol Med (Berl)"},{"issue":"9 Supplement","key":"445_CR82","doi-asserted-by":"publisher","first-page":"P6-14-06","DOI":"10.1158\/1538-7445.SABCS14-P6-14-06","volume":"75","author":"Z Mu","year":"2015","unstructured":"Mu Z, Jiao X, Pestell RG, Cristofanilli M. Abstract P6-14-06: CCR5 antagonists suppresses the migration and invasion of human inflammatory breast cancer cells. Cancer Res. 2015;75(9 Supplement):P6-14-06. P6\u201314-06","journal-title":"Cancer Res"},{"issue":"2","key":"445_CR83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.canlet.2012.09.023","volume":"328","author":"M Qiu","year":"2013","unstructured":"Qiu M, Peng QH, Jiang I, Carroll C, Han GZ, Rymer I, et al. Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells. Cancer Lett. 2013;328(2):261\u201370. PubMed PMID: WOS:000313138000010. English","journal-title":"Cancer Lett"},{"issue":"7","key":"445_CR84","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/bjc.2013.534","volume":"109","author":"P Liu","year":"2013","unstructured":"Liu P, Kumar IS, Brown S, Kannappan V, Tawari PE, Tang JZ, et al. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. Br J Cancer. 2013;109(7):1876\u201385. PubMed PMID: 24008666. Pubmed Central PMCID: 3790184","journal-title":"Br J Cancer"},{"issue":"50","key":"445_CR85","doi-asserted-by":"publisher","first-page":"E5429","DOI":"10.1073\/pnas.1421438111","volume":"111","author":"D Samanta","year":"2014","unstructured":"Samanta D, Gilkes DM, Chaturvedi P, Xiang L, Semenza GL. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci U S A. 2014;111(50):E5429\u201338. PubMed PMID: 25453096. Pubmed Central PMCID: 4273385","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"445_CR86","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/onc.2008.207","volume":"27","author":"H Korkaya","year":"2008","unstructured":"Korkaya H, Paulson A, Iovino F, Wicha MS. HER2 regulates the mammary stem\/progenitor cell population driving tumorigenesis and invasion. Oncogene. 2008;27(47):6120\u201330. PubMed PMID: 18591932. Pubmed Central PMCID: 2602947","journal-title":"Oncogene"},{"issue":"24","key":"445_CR87","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1158\/0008-5472.CAN-12-4704","volume":"73","author":"E Charafe-Jauffret","year":"2013","unstructured":"Charafe-Jauffret E, Ginestier C, Bertucci F, Cabaud O, Wicinski J, Finetti P, et al. ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program. Cancer Res. 2013;73(24):7290\u2013300. PubMed PMID: 24142344","journal-title":"Cancer Res"},{"issue":"2","key":"445_CR88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00109-013-1102-5","volume":"92","author":"LS Xiang","year":"2014","unstructured":"Xiang LS, Gilkes DM, Chaturvedi P, Luo WB, Hu HX, Takano N, et al. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer. J Mol Med-Jmm. 2014;92(2):151\u201364. PubMed PMID: WOS:000330980000006. English","journal-title":"J Mol Med-Jmm"},{"key":"445_CR89","doi-asserted-by":"crossref","unstructured":"Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Research. 2008;10(2):R25. PubMed PMID: WOS:000255941100013. English.","DOI":"10.1186\/bcr1982"},{"issue":"12","key":"445_CR90","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.cellsig.2015.08.015","volume":"27","author":"MC Peeters","year":"2015","unstructured":"Peeters MC, Fokkelman M, Boogaard B, Egerod KL, van de Water B, IJ AP, et al. The adhesion G protein-coupled receptor G2 (ADGRG2\/GPR64) constitutively activates SRE and NFkappaB and is involved in cell adhesion and migration. Cell Signal. 2015;27(12):2579\u201388. PubMed PMID: 26321231","journal-title":"Cell Signal"},{"issue":"11","key":"445_CR91","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1529\/biophysj.108.133116","volume":"95","author":"PP Provenzano","year":"2008","unstructured":"Provenzano PP, Inman DR, Eliceiri KW, Trier SM, Keely PJ. Contact guidance mediated three-dimensional cell migration is regulated by rho\/ROCK-dependent matrix reorganization. Biophys J. 2008;95(11):5374\u201384.","journal-title":"Biophys J"},{"issue":"6","key":"445_CR92","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1083\/jcb.201201003","volume":"197","author":"AS Meyer","year":"2012","unstructured":"Meyer AS, Hughes-Alford SK, Kay JE, Castillo A, Wells A, Gertler FB, et al. 2D protrusion but not motility predicts growth factor\u2013induced cancer cell migration in 3D collagen. J Cell Biol. 2012;197(6):721\u20139.","journal-title":"J Cell Biol"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-017-0445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-017-0445-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-017-0445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:46:04Z","timestamp":1589539564000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-017-0445-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s12918-017-0445-x","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]},"assertion":[{"value":"30 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"68"}}